Financial Ratios

SAFAL HERBS LTD.

NSE : NABSE : 532034ISIN CODE : INE880M01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE1.380 (0 %)
PREV CLOSE ( ) 1.38
OPEN PRICE ( ) 1.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5684
TODAY'S LOW / HIGH ( )1.26 1.38
52 WK LOW / HIGH ( ) 1.261.38
NSE
This Company is not listed in NSE
Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Operational & Financial Ratios
   Earnings Per Share (Rs)0.000.000.000.000.00
   CEPS(Rs)0.000.000.000.000.00
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.880.880.880.890.88
   Tax Rate(%)26.000.000.0030.9030.90
Margin Ratios
   Core EBITDA Margin(%)-46.77-10.01-7.39-0.58
   EBIT Margin(%)-31.82-4.061.141.14
   Pre Tax Margin(%)-31.94-4.081.141.14
   PAT Margin (%)-31.94-4.080.790.79
   Cash Profit Margin (%)-31.94-4.080.790.79
Performance Ratios
   ROA(%)0.02-0.35-0.150.150.12
   ROE(%)0.02-0.36-0.160.160.13
   ROCE(%)0.03-0.36-0.160.230.18
   Asset Turnover(x)0.000.010.040.190.15
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.000.010.040.200.29
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.000.00
   Receivable days910.99178.0427.12189.76
   Inventory Days0.000.000.000.00
   Payable days514.96100.4329.0750.35
Valuation Parameters
   PER(x)7365.110.000.002707.146807.06
   PCE(x)7365.11-544.08-2016.292717.966807.06
   Price/Book(x)1.571.993.174.288.57
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)173.6082.2521.3453.58
   EV/Core EBITDA(x)4954.72-545.49-2027.201873.174689.86
   EV/EBIT(x)4954.72-545.49-2027.201873.174689.86
   EV/CE(x)1.541.943.054.218.15
   M Cap / Sales173.7982.3521.3553.63
Growth Ratio
   Net Sales Growth(%)-100.00-70.38-80.8425.57-1.76
   Core EBITDA Growth(%)108.67-132.31-168.2425.20-59.93
   EBIT Growth(%)108.67-132.31-168.2425.20-59.93
   PAT Growth(%)105.83-131.62-199.5925.22-59.93
   EPS Growth(%)105.86-128.57-200.0025.72-95.99
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)859.67160.5349.32684.1716.86
   Quick Ratio(x)859.67160.5349.32684.1716.86
   Interest Cover(x)11.22-272.04-149.94549.37498.38
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.